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Direct N-glycofunctionalization of amides with glycosyl 
trichloroacetimidate by thiourea/halogen bond donor co-catalysis 
Yusuke Kobayashi,[a] Yuya Nakatsuji,[a] Shanji Li,[a] Seiji Tsuzuki,[b] Yoshiji Takemoto*[a] 
 
Abstract: Using a halogen bond (XB) donor and Schreiner’s 
thiourea as cooperative catalysts, various amides, including the 
asparagine residues of several peptides, were directly coupled with 
glycosyl trichloroacetimidates to give unique N-acylorthoamides in 
good yields. Synthetic applications of N-acylorthoamides, including 
rearrangement to the corresponding -N-glycoside, were also 
demonstrated.  
N-Glycosides are found in various pharmaceuticals, biologically 
active compounds, and natural products.
[1]
 They can be used in 
material science as glycolipids for lipid nanotubes.
 [2]
 Sugar moieties 
are known to impart hydrophilicity to molecules, and alter the higher 
order structure and bioavailability of molecules.
[3]
 Several N-
glycosides have been utilized as prodrugs to improve delivery to 
target tissues and organs.
[4]
 However, synthetic methodologies for 
N-glycosylamides are not as well developed
[5‒8] as those for O-
glycosides (Scheme 1a).
[9]
 Among the reported synthetic methods 
for N-glycosylamides,
 [6]
 direct N-glycosylation of amides is the most 
straightforward but challenging approach because of the poor 
nucleophilicity of the amides, and only limited catalytic conditions 
have been reported to date.
[8]
 However, there still remains to be 
improved concerning scope of amides and the accessibility of 
Leaving group (LG). In fact, direct introduction of asparagine 
residues of peptides have been rarely investigated,
 
and the use of 
tripeptide significantly decreased the chemical yield,
[8a]
 as compared 
with that of dipeptide.
[8a,c]
 We then focused on the utilization of 
glycosyl trichloroacetimidates,
[10]
 which are regarded as one of the 
most readily available glycosyl donors and activated under relatively 
mild condition.
[11a,b]
 On the other hand, undesired glycosyl 
trichloroacetamide was obtained as byproduct, especially when the 
glycosyl acceptor (Nu-H) has low nucleophilicity (path c).
[8a]
 Herein, 
we report two different catalytic systems, which offers a solution to 
these problems (Scheme 1b). We envisaged that the activation of 
glycosyl trichloroacetimidates under mildly acidic condition would 
afford kinetically favored product by the preferential addition of 
employed amides via path a.
[10]
 We thus focused on Schreiner’s 
thiourea,
[12]
 whose pKa value was reported to be 8.5 in DMSO.
[12c]
 





 of alcohols, its acidity was insufficient to activate 
trichloroacetimidate.
[11a,b]
 We envisioned that a soft and mild Lewis 




  H) as halogen bond (XB) 
donor,
 [15‒17] used as a co-catalyst would interact with the soft Lewis 
basic moiety of thiourea
[18] 
to increase the HB-donating ability of 
thiourea,
[19]
 so that the LG could be activated
[20]
 with wide functional 
group tolerance. The produced N-acylorthoamides
[21]
 would serve as 
intermediates for thermodynamically favored -N-glycosides
[10]
 
(Scheme 1a, path d, Nu = amide), and offer a unique traceless N-
glycofunctionalization of amide, impacting on prodrug synthesis. In 
fact, during the course of our investigation on the rearrangement of 
N-acylorthoamide to N-glycoside (path d), we have developed a new 
type of Brønsted-acid-salt catalyst, comprised of Brønsted acid and 
2-halogenated azole, which was found to be an efficient catalyst for 
the direct N-glycosylation of various amides utilizing the same 
glycosyl trichloroacetimidates (path b and/or path a and d).  
 
 
Scheme 1. Summary of this work  
We first screened various catalysts for the direct N-
glycofunctionalization of a protected asparagine derivative 2a
[8]
 with 
a readily accessible glycosyl donor 1
[22a]
 (Table 1). The use of 
Schreiner’s thiourea (5) on its own did not promote the reaction at all 
(entry 1). We next investigated several co-catalysts for activation of 
thiourea,
[19]
 including metallic Lewis acids (entries 2‒5)
[11c]
 and 
Brønsted acids (entries 6‒7).
[11a]
 Interestingly, when a substituted 
diarylphosphoric acid was employed, an N-acylorthoamide 4a, 
whose structure was fully characterized using spectral data (Figure 
S5),
 
was obtained in 22% yield (entry 6). A stronger Brønsted acid 
resulted in the production of 3a, albeit in 26% yield (entry 7), 
indicating that the acidity of the catalyst affects production of 3a. 
Indeed, as previously reported, with 10 mol % of trimethylsilyl 
trifluoromethanesulfonate (TMSOTf)
 [8]
 as a conventional Lewis acid, 
the donor 1 was immediately consumed, and 3a was obtained in 
25% yield (entry 8), along with several inseparable byproducts. As 
the results were not satisfactory, we next investigated several XB 
donors as cooperative catalysts (entries 9‒12). We found that 
combination of thiourea 5 with 2-iodobenzimidazolium-type XB 
donors 7b
[14]
 afforded 4a as a major product in 66% yield (entry 11). 
A newly designed XB donor with extended aromatic rings 7c 
similarly afforded 4a as the major product (entry 12). The XB donor 
7b on its own did not afford the target products (entry 13), which 
indicated that combination of thiourea 5 and XB donor 7b was 
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essential for production of 4a. The yields of 4a greatly decreased 
when the squaramide
[23]





 was employed instead of 5 (entries 14 and 15). In 
addition, a control experiment using non-halogenated azolium salt 8 
did not afford 4a at all (entry 16). These results suggest that the 
reaction was not accelerated by the azoliium cation moiety or triflate 
anion by itself,
[24]
 and that XB formation between the sulfur atom of 5 
and the iodine atom of XB donor 7
[15d,18a,b,d]
 plays an important role 
for the promotion of the reaction, presumably through the activation 
of LG (Scheme S1).
[25]
 Although other solvents, such as THF, 
toluene, and acetonitrile, can be used for this reaction without 
significant decrease of the chemical yields (entries 17‒19), CH2Cl2 
was chosen for further investigation in terms of the solubility of 
various amides. To gain further support for the XB formation, a 
13
C 
NMR experiment was performed using thiourea (5) and XB donor 
(7b) (Figure S2).
[25]
 When 1.0 equivalent of 5 was added, the 
13
C 
NMR peak of the C2 position of 7b broadened and shifted downfield 





Table 1: Screening of reaction conditions for orthoamide 4 
 
entry catalyst solvent 3a (%)a 4a (%)a 
(%)a 1 5 CH2Cl2 0
 b 0 b 
2 5 + BF3•OEt2 CH2Cl2 7   0 b 
3 5 + Sc(OTf)3 CH2Cl2 0 b 0 b 
4 5 + AuCl3 CH2Cl2 trace 0 b 
5 5 + PPh3AuOTf  CH2Cl2 trace 0
 b 
6 5 + (4-NO2C6H4O)2P(O)OH  CH2Cl2 0 b 22 
7 5 + TfOH  CH2Cl2 26 0 b 
8c TMSOTf CH2Cl2 25 0 b  
9 5 + C6F5I CH2Cl2 0
 b 0 b 
10 5 + 7a CH2Cl2 5  32 
11 5 + 7b CH2Cl2 7 66 
12 5 + 7c CH2Cl2 8 63 
13 7b CH2Cl2 0
 b 0 b 
14 6 + 7b CH2Cl2 2 19 
15 6 CH2Cl2 0 b 0 b 
16 5 + 8 CH2Cl2 0 b 0 b 
17 5 + 7b THF 3 64 
18 5 + 7b toluene 15 66 
19 5 + 7b CH3CN 4 53 
[a] Isolated yields. [b] Not detected. [c] 58% of 2a was recovered. 
It is worth noting that under the optimized condition (Table 1, entry 
11), neither N-trichloroacetylorthoamide nor glycosyl 
trichloroacetamide were obtained, even additional trichloroacetamide 
(1.0 equiv) was employed (Scheme 2a), presumably due to the 
inherent reactivity of the acyloxonium ion intermediate toward 
nucleophiles.
[10]
 Encouraged by this result, we then investigated the 
efficient catalysts to promote the rearrangement of 4a to 3a (Scheme 
2b). Although the chemical yields of 3a were low using TMSOTf
[10c]
 
and TfOH as catalysts, partly because of the degradation of 4a, 
Brønsted acid salt 9•TfOH, synthesized from the same intermediate 
for 7c, was found to be most suitable. 
 
Scheme 2: (a) Control experiment using trichloroacetamide (b) Catalytic 
rearrangement of 4a to 3a 
 
Scheme 3: Substrate scope for the synthesis of N-acylorthoamides 4. Isolated 
yields were indicated. Rib = ribose.  
 
Scheme 4: Substrate scope for the synthesis of N-acylorthoamides 9.  
Isolated yields were indicated. Glc = glucose. N.d. = not detected. 
Having established the synthetic utilities of N-acrylorthoamide 4, we 
next investigated the substrate scope for glycosyl donors and 
amides (Scheme 3, 4). Using 10 mol % of catalysts 5 and 7b, N-
Cbz-glycineamide (2b) could be directly converted into 4b in 67% 
yield. Oleamide (2c), which is an important amide towards the 
synthesis of lipid nanotubes,
[2]
 was effectively conjugated with sugar 
to afford 4c in 41% yield. Notably, the asparagine residues of 
dipeptide and tripeptide were glycosylated by the present co-
catalytic system to afford 4e and 4f in unprecedented good yields 
(Scheme 3). The same amides were also coupled with the glucose 
surrogate utilizing 3,4,6-tri-O-benzyl-2-O-acetyl--D-glucopyranosyl 
trichloroacetimidate (10)
[22b]
 to yield N-acylorthoamides 11a‒f in 56‒
71% yields (Scheme 4).  
We next focused on the direct N-glycosylation utilizing Brønsted acid 
salt 9•TfOH (Scheme 5), as the acidity of the catalyst was supposed 
to be important to obtain N-glycoside 3a in Table 1 (entry 7, 8). To 
our delight, N-glycoside 12 was obtained in 72% yield, when glycosyl 
donor 10 and amide 2a were reacted. 
 
A slight improvement of the 





yield was observed when thiourea 5 was employed as co-catalyst. 
[26]
 Under the optimized reaction conditions, a series of N-glycoside 
12a‒f were obtained in 62‒82% yields as single -isomers. In 
addition to the glucose-derived donor 10, a ribose-derived donor 1 
could be directly incorporated into amides to afford the 
corresponding adducts in 45‒80% yields. Again, the conjugation with 
tripeptide proceeded with unprecedented good yields. Notably, the 
catalyst 9•TfOH could be readily prepared from the commercial 
source in three steps with high yields, and found to be air- and 
moisture-stable for several months.  
 
Scheme 5: Substrate scope for direct N-glycosylation using catalyst 9•TfOH. 
[a] With 10 mol % of 5. [b] Without 5. Glc = glucose, Rib = ribose. 
The utilities of the present reactions have been clearly demonstrated 
by their application to the syntheses of natural products
[27]
 (Scheme 
6a), and the modification of pharmaceuticals to prodrugs (Scheme 
6b). The direct N-glycosylation of a substituted 2-phenylacetamide 
2g with glycosyl donor 10 proceeded very smoothly to obtain the 
desired adduct 12g in excellent yield. The successive deprotection 
of acetyl and benzyl groups afforded the product in almost 
quantitative yield (Scheme 6a). The methodologies developed in this 
paper are particularly useful when the compound to be 
functionalized has only an amide group for a traceless modification, 
and this strategy is especially true for pharmaceuticals. For example, 
the anticancer drug temozolomide (2h) can be transformed into the 
corresponding N-acylorthoamide 11h using glycosyl donor 10 with 
10 mol % of 5 and 7b in THF. After deprotection of the benzyl group 
of 11h, the product 15h was found to be soluble in protic solvents, 
such as methanol, while temozolomide itself is almost insoluble.
[28] 
Practically, commercially available glycosyl donor 16 can be 
converted into the corresponding adduct 17h in 61% yield. It was 
noted that hydrolysis of the N-adduct 17h under mildly acidic 
conditions afforded temozolomide (Scheme 6c). 
In conclusion, we have developed two different catalytic systems for 
the synthesis of N-acylorthoamides and N-glycosides with wide 
functional group tolerance. The XB interaction plays an important 
role in the production of N-arylorthoamides via the activation of LG 
under mildly acidic condition. The combination of a XB donor with a 
relatively soft XB acceptor will allow for otherwise inaccessible 
transformations, and broaden the utility of XB donor catalysis. In 
addition, halogenated azolium salts 9•TfOH can be utilized for direct 
N-glycosylation as novel bench-stable Brønsted acid. Both 
methodologies will be powerful for the molecular transformation of 
amides, and offer a new tool for the traceless modification of 
pharmaceuticals. Further investigation on the details of the reaction 
mechanism, including complexation of amides, and substrate scope 
is now underway in our laboratory. 
 
Scheme 6:  Application of the present N-glycofunctionalization 
Experimental Section 
To a stirred solution of glycosyl donor 1 (36.4 mg, 0.06 mmol) and amide 
2a (1.0 equiv, 0.05 mmol) in DCM (1.0 mL) was added activated MS 4Å 
(50 mg), and the reaction mixture was stirred at the ambient temperature 
for 10 min. Then, the catalysts 5 (2.5 mg, 10 mol %) and 7b (3.5 mg, 10 
mol %) were added, and the resulting mixture was stirred at the ambient 
temperature for 24 hours. After the MS 4Å was filtered off and washed 
with chloroform, the filtrate was concentrated under reduced pressure to 
give crude N-acylorthoamide, which was purified by silica gel column 
chromatography to afford 4a (24.8 mg, 66%), along with 3a (2.6 mg, 7%).  
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Using a halogen bond (XB) donor and Schreiner’s thiourea as cooperative catalysts, 
various amides, including the asparagine residues of several peptides, were directly 
coupled with glycosyl trichloroacetimidates to give unique N-acylorthoamides in 
good yields. Synthetic applications of N-acylorthoamides, including rearrangement 
to the corresponding -N-glycoside, were also demonstrated.  
 
Yusuke Kobayashi, Yuya Nakatsuji, 
Shanji Li, Seiji Tsuzuki, Yoshiji 
Takemoto* 
Page No. – Page No. 
Direct N-glycofunctionalization of 
amides with glycosyl 
trichloroacetimidate by 




Keywords: glycosylation • organocatalyst • XB donor  
 
 
 
